Information:
Error:
ID
26894
Description
Tamoxifen Citrate in Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00963209
Link
https://clinicaltrials.gov/show/NCT00963209
Keywords
Versions (1)
- 10/28/17 10/28/17 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
October 28, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00963209
Eligibility Breast Cancer NCT00963209
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00963209
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Breast Carcinoma
Item
diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Breast Carcinoma Hormone Responsive | Estrogen receptor positive Percentage Immunohistochemistry | Progesterone receptor positive Percentage Immunohistochemistry
Item
hormone-sensitive breast cancer defined as > 10% estrogen receptor and/or > 10% progesterone receptor positivity by immunohistochemistry
boolean
C0678222 (UMLS CUI [1,1])
C1512498 (UMLS CUI [1,2])
C0279754 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
C0279759 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
C0021044 (UMLS CUI [3,3])
C1512498 (UMLS CUI [1,2])
C0279754 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0021044 (UMLS CUI [2,3])
C0279759 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
C0021044 (UMLS CUI [3,3])
Tamoxifen Citrate | Exposure to High dose
Item
receiving treatment with tamoxifen citrate and must be eligible for exposure to higher doses
boolean
C0079589 (UMLS CUI [1])
C0332157 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
C0332157 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Exclusion Criteria | Deep Vein Thrombosis | Pulmonary Embolism
Item
no history of deep venous thrombosis or pulmonary embolism
boolean
C0680251 (UMLS CUI [1])
C0149871 (UMLS CUI [2])
C0034065 (UMLS CUI [3])
C0149871 (UMLS CUI [2])
C0034065 (UMLS CUI [3])
Exclusion | Endometrial Carcinoma
Item
no history of endometrial carcinoma
boolean
C2828389 (UMLS CUI [1])
C0476089 (UMLS CUI [2])
C0476089 (UMLS CUI [2])
Exclusion Criteria | Vaginal Hemorrhage | Endometriosis | Endometrial Hyperplasia | Endometrial hypertrophy | Polyps
Item
no known history of vaginal bleeding, endometriosis, endometrial hyperplasia, endometrial hypertrophy, and/or polyps
boolean
C0680251 (UMLS CUI [1])
C2979982 (UMLS CUI [2])
C0014175 (UMLS CUI [3])
C0014173 (UMLS CUI [4])
C0858833 (UMLS CUI [5])
C0032584 (UMLS CUI [6])
C2979982 (UMLS CUI [2])
C0014175 (UMLS CUI [3])
C0014173 (UMLS CUI [4])
C0858833 (UMLS CUI [5])
C0032584 (UMLS CUI [6])
Exclusion Criteria | Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0680251 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0032961 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
Exclusion | Medical contraindication Tamoxifen Citrate
Item
no contraindication to tamoxifen citrate treatment
boolean
C2828389 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0079589 (UMLS CUI [2,2])
C1301624 (UMLS CUI [2,1])
C0079589 (UMLS CUI [2,2])
Exclusion Criteria | Midazolam allergy | Hypersensitivity Dextromethorphan
Item
no known allergy to midazolam or dextromethorphan
boolean
C0680251 (UMLS CUI [1])
C0570821 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0011816 (UMLS CUI [3,2])
C0570821 (UMLS CUI [2])
C0020517 (UMLS CUI [3,1])
C0011816 (UMLS CUI [3,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.12
Item
see disease characteristics
boolean